Sunday, May 4, 2014

Biomet Metal-on-Metal Hip Implant Litigation Update: $56 Million Settlement Approved; Qualified

Qualified Biomet Patients Need to File Lawsuit by April 15, 2014

Device maker, Biomet Inc., announced that it will be pay at least $56 million to settle the MDL which involves consumer claims that the device maker manufactured a defective metal-on-metal hip implant device that may lead to serious metal ion build-up in patients' bodies. Allegations also include that the device may lead to metallosis (metal poisoning), difficulty walking, pain, and premature hip failure. These issues may, in turn, lead to a need for revision surgery to remove and replace the device.

This settlement agreement extends to all cases currently pending in the Biomet MDL, and any future cases filed in a federal court on or before April 15, 2014. The agreement received approval from U.S. District Judge Robert L. Miller Jr. (In re: Biomet M2A Magnum Hip Implant Products Liability Litigation, case number 3:12-md-02391, in the U.S. District Court for the Northern District of Indiana)

According to the settlement's definition, a qualified plaintiff is defined as a plaintiff who was implanted with a Biomet M2a-38 or M2a-Magnum hip implant and who later required that metal hip device to be "revised"--removed or repaired. Each of these qualified individuals will receive a base payment of $200,000; however, there are a number of variations to this amount, according to Law360, which are bas

Read more:

No comments:

Post a Comment